Yes. Injectable L-Arginine is a compounded prescription preparation dispensed pursuant to a valid prescription from a licensed healthcare provider. A telehealth consultation and medical intake are required to confirm clinical suitability, establish the appropriate administration route and dosing, and screen for relevant cardiovascular and metabolic contraindications.

Injectable L-Arginine is generally well tolerated at therapeutic doses. Common side effects may include nausea, GI upset, diarrhea, and a sensation of warmth or flushing consistent with nitric oxide-mediated vasodilation. At higher doses or infusion rates, hypotension (low blood pressure) may occur, patients with existing cardiovascular conditions should be monitored accordingly. Injection site reactions may occur with IM administration. Report any unusual cardiovascular symptoms including significant dizziness, palpitations, or chest discomfort to your provider promptly.

L-Arginine is not appropriate for patients with a history of recurrent herpes simplex virus outbreaks who are not on antiviral suppressive therapy, as arginine can support viral replication in susceptible individuals. Patients with significant renal or hepatic impairment, or conditions causing electrolyte imbalances, require individualized provider evaluation. Patients with known urea cycle disorders should not use arginine supplementation without specialist guidance. Safety during pregnancy and breastfeeding has not been established for injectable use.

L-Arginine's nitric oxide-enhancing activity may produce additive blood pressure-lowering effects when combined with antihypertensive medications, PDE5 inhibitors (sildenafil, tadalafil), or other nitric oxide donors, potentially causing significant hypotension. Patients on anticoagulants should be monitored, as arginine may have effects on platelet activity and coagulation. Concurrent use with potassium-sparing diuretics or ACE inhibitors requires monitoring for hyperkalemia. Always provide a complete medication list to your provider before beginning treatment.

Patients with cardiovascular disease, renal impairment, hepatic conditions, or a history of herpes simplex virus require individualized assessment. Those already on antihypertensive, nitric oxide-modulating, or erectile function medications require careful dose coordination to avoid additive hypotension. Your provider will determine appropriateness and establish appropriate monitoring based on your complete medical and medication history.